Insight Pharma Reports Announces Ocular Disorders: Rising Therapeutics, Technologies, and Devices
Cambridge Innovation InstituteThe newly released Insight Pharma Report covers a handful of companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.